Influence of TNF and IL10 gene polymorphisms in the immunopathogenesis of leprosy in the south of Brazil.

Int J Infect Dis

Laboratório de Imunogenética, Departamento de Análises Clínicas, Universidade Estadual de Maringá, Av. Colombo, 5790, Maringá, PR, CEP 87020-900, Brazil.

Published: July 2009

Objective: To determine whether cytokine polymorphisms are associated with leprosy and/or their subtypes in a Brazilian population.

Methods: Genotyping using polymerase chain reaction with sequence-specific primers (PCR-SSP) was performed for: TNF(-308/-238), IL2(-330/+166), IL6(-174), IFNG(+874), TGFB1(+869/+915), and IL10(-592/-819/-1082) in 240 healthy controls and 167 patients with leprosy.

Results: For TNF(-308), a higher frequency of GG genotype (85.5% vs. 74.1% in healthy controls, p = 0.009), along with a decreased frequency of GA/AA genotypes was observed among leprosy patients as compared to the control group (14.5% vs. 25.9%, p = 0.009). The GG genotype was particularly higher in patients with tuberculoid (TT) and borderline (BB) leprosy (90.5% and 89.8%, respectively). Analysis of IL10 genotypes revealed a lower frequency of GCC/GCC haplotype in lepromatous leprosy (LL) patients (6.2%) in comparison to controls (15.4%).

Conclusion: It is suggested that the G-->A substitution at position -308 in the TNF promoter region plays an important role in leprosy patients.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijid.2008.08.019DOI Listing

Publication Analysis

Top Keywords

leprosy patients
12
healthy controls
8
leprosy
6
patients
5
influence tnf
4
tnf il10
4
il10 gene
4
gene polymorphisms
4
polymorphisms immunopathogenesis
4
immunopathogenesis leprosy
4

Similar Publications

This study analyzed the trend and factors associated with medical-surgical complications in patients discharged from leprosy multidrug therapy at the Centre Hospitalier Régional Spécialisé (CHRS), in Macenta, Republic of Guinea. This was a retro 2012 ( = 54) and 2013 ( = 35) and then a slight decrease between 2014 ( = 34) and 2017 ( = 26). From 2019 ( = 18) to 2021 ( = 1), a significant d spective study using routine secondary data from 2012 to 2021.

View Article and Find Full Text PDF

A conserved human CD4+ T cell subset recognizing the mycobacterial adjuvant, trehalose monomycolate.

J Clin Invest

December 2024

Department of Molecular Immunology, Research Institute for Microbial Diseas, Osaka University, Suita, Japan.

Mycobacterium tuberculosis causes human tuberculosis. As mycobacteria are protected by thick lipid cell wall, humans have developed immune responses against diverse mycobacterial lipids. Most of these immunostimulatory lipids are known as adjuvants acting through innate immune receptors, such as C-type lectin receptors.

View Article and Find Full Text PDF

Purpose: Neurotrophic keratopathy is part of the leprosy sequelae and causes progressive deterioration of visual acuity. Although leprosy is bacteriologically curable, there is currently no efficient treatment. Eye drops containing tetrapeptides, phenylalanine-glycine-leucine-methionine-amide (FGLM-NH) and serine-serine-serine-arginine (SSSR), derived from substance P and insulin-like growth factor 1, are clinically efficacious in the treatment of corneal epithelial disorders caused by neurotrophic keratopathy.

View Article and Find Full Text PDF

Background: The Karamoja subregion is a high TB burden pastoralist community that previously had limited access to public health services. We explored the community's perceptions towards TB to better understand how healthcare services should be structured to meet the needs of the persons with TB and their households.

Methods: From September to October 2022, we conducted 12 focus group discussions (FGDs) and interviewed 95 persons (48 community members and 47 health workers).

View Article and Find Full Text PDF

Background: Directly observed therapy (DOT) is the standard for monitoring adherence for tuberculosis (TB) treatment. However, the implementation of DOT is difficult for patients and providers due to a lack of financial and human resources. Mounting evidence suggests that emerging digital adherence technologies like video directly observed therapy (VDOT) can serve as an option.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!